Oxehealth

Oxehealth specializes in innovative patient monitoring solutions for mental health facilities, enhancing care quality through contact-free technology. They focus on improving operational efficiency and patient safety in healthcare settings. Founded in 2012 in Oxford, UK, Oxehealth provides advanced monitoring solutions for mental health institutions. The company was co-founded by Hugh Lloyd-Jukes and Lionel Tarassenko, with Lloyd-Jukes also serving as the CEO.

The company has raised a total of GBP 3 million across three funding rounds, with the most recent round occurring on October 20, 2017, led by Longview Innovation. Their current company valuation stands at GBP 14. 23 million. Oxehealth offers a patient monitoring platform tailored for mental health hospitals, featuring two pioneering medical devices that capture physiological data without the need for wearables.

This technology supports healthcare staff by enhancing data collection and situational awareness, crucial for patient care from admission to discharge. Their clientele includes various mental health service providers in the UK and the US, addressing the challenges posed by staffing shortages and safety concerns. In 2023, Oxehealth reported revenues of GBP 5,904,644. 10 with an EBITDA of GBP -7,455,571.

30. Their revenue model is centered on service agreements with mental health facilities, allowing for continuous access to their monitoring platform, thereby integrating Oxehealth’s technology into everyday operations for improved patient care. Following the GBP 3 million funding round in October 2017, Oxehealth plans to expand its technology deployment across the NHS. The funding will facilitate wider adoption of their platform, enhancing patient monitoring capabilities and addressing the specific needs of mental health services.

The company is expected to target additional markets in the coming years to broaden its reach.